Corium, LLC received publication of European Patent Application EP3490559A1 for transdermal delivery systems engineered to match the pharmacokinetic profile of oral administration. The application claims formulations containing A61K 31/445, 31/13, and 31/137 compounds in A61K 9/70 transdermal matrix systems, targeting A61P 25/28 neurological applications. Inventors include Parminder Singh, Eun Soo Lee, and Amit K. Jain.

Pharmaceutical companies and drug manufacturers should note this patent publication for freedom-to-operate considerations when developing transdermal delivery formulations for neurological therapies. No compliance action is required; this is an informational publication of intellectual property rights. Patent protection extends to designated EPO states including DE, FR, GB, IT, ES, and 26 other member jurisdictions.